Lopez, Milyn B.

HRN: 25-73-14  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/04/2024
CEFUROXIME 750MG (VIAL)
09/04/2024
09/10/2024
IV
1500mg
On Call To OR
LTCS
Waiting Final Action 
09/04/2024
CEFUROXIME 1.5GM (VIAL)
09/04/2024
09/05/2024
IVT
1.5 Gms
Q8
LLTCS
Waiting Final Action 
09/04/2024
CEFUROXIME 500MG (TAB)
09/05/2024
09/12/2024
PO
500mg
BID
LTCS
Waiting Final Action 
09/04/2024
MUPIROCIN 2%, 15G (TUBE)
09/04/2024
09/11/2024
TOPICAL
Apply To Affected Area
TiD
S/P LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: